NCT01480089View on ClinicalTrials.gov

Surgical Pain Control With Ropivacaine by Atomized Delivery

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Pain
Interventions
DRUG

Intraperitoneal Ropivacaine (AIR)

Ropivacaine 2 mg/kg per lean body mass up to no more than 200mg total dose will be atomized and delivered into the peritoneal cavity at the completion of surgery.

DRUG

Atomized Intraperitoneal Saline (AIS)

Atomized saline will be administered to the peritoneal cavity at the completion of surgery.

Trial Locations (1)

60153

Loyola University Medical Center, Maywood

All Listed Sponsors
lead

Loyola University

OTHER

NCT01480089 - Surgical Pain Control With Ropivacaine by Atomized Delivery | Biotech Hunter | Biotech Hunter